{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:55:55Z","timestamp":1791453355646,"version":"4.3.3"},"reference-count":64,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>There is evidence that berberine (BBR), a clinically relevant plant compound, ameliorates clinically apparent collagen-induced arthritis (CIA) in vivo. However, to date, there are no studies involving the use of BBR which explore its prophylactic potential in this model of rheumatoid arthritis (RA). The aim of this study was to determine if prophylactic BBR use during the preclinical phase of collagen-induced arthritis would delay arthritic symptom onset, and to characterize the cellular mechanism underlying such an effect. DBA\/1J mice were injected with an emulsion of bovine type II collagen (CII) and complete Freund\u2019s adjuvant (day 0) and a booster injection of CII in incomplete Freund\u2019s adjuvant (day 18) to induce arthritis. Mice were then given i.p. injections of 1 mg\/kg\/day of BBR or PBS (vehicle with 0.01% DMSO) from days 0 to 28, were left untreated (CIA control), or were in a non-arthritic control group (n = 15 per group). Incidence of arthritis in BBR-treated mice was 50%, compared to 90% in both the CIA and PBS controls. Populations of B and T cells from the spleens and draining lymph nodes of mice were examined on day 14 (n = 5 per group) and day 28 (n = 10 per group). BBR-treated mice had significantly reduced populations of CD4+Th and CD4+CXCR5+ Tfh cells, and an increased proportion of Foxp3+ Treg at days 14 and 28, as well as reduced expression of co-stimulatory molecules CD28 and CD154 at both endpoints. The effect seen on T cell populations and co-stimulatory molecule expression in BBR-treated mice was not mirrored in CD19+ B cells. Additionally, BBR-treated mice experienced reduced anti-CII IgG2a and anti-CII total IgG serum concentrations. These results indicate a potential role for BBR as a prophylactic supplement for RA, and that its effect may be mediated specifically through T cell suppression. However, the cellular effector involved raises concern for BBR prophylactic use in the context of vaccine efficacy and other primary adaptive immune responses.<\/jats:p>","DOI":"10.3390\/ijms22073522","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T16:01:57Z","timestamp":1617033717000},"page":"3522","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Berberine Delays Onset of Collagen-Induced Arthritis through T Cell Suppression"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-0601","authenticated-orcid":false,"given":"Alexandra A.","family":"Vita","sequence":"first","affiliation":[{"name":"School of Biological Sciences, University of Northern Colorado, Greeley, CO 80639, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Aljobaily","sequence":"additional","affiliation":[{"name":"Department of Applied Statistics and Research Methods, University of Northern Colorado, Greeley, CO 80639, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-9105","authenticated-orcid":false,"given":"David O.","family":"Lyons","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Northern Colorado, Greeley, CO 80639, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4014-9278","authenticated-orcid":false,"given":"Nicholas A.","family":"Pullen","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Northern Colorado, Greeley, CO 80639, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/1756-185X.13333","article-title":"CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis","volume":"21","author":"Gupta","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13075-017-1445-3","article-title":"Right drug, right patient, right time: Aspiration or future promise for biologics in rheumatoid arthritis?","volume":"19","author":"Vital","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/annrheumdis-2014-206047","article-title":"Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: Does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts","volume":"74","author":"Tsonaka","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/ard.2010.139212","article-title":"Predictors of response to methotrexate in early DMARD na\u00efve rheumatoid arthritis: Results from the initial open-label phase of the SWEFOT trial","volume":"70","author":"Saevarsdottir","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrrheum.2017.185","article-title":"Preventing progression from arthralgia to arthritis: Targeting the right patients","volume":"14","author":"Huizinga","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_7","first-page":"1631","article-title":"Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study","volume":"29","author":"Aletaha","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ebina, K., Hashimoto, M., Yamamoto, W., Ohnishi, A., Kabata, D., Hirano, T., Hara, R., Katayama, M., Yoshida, S., and Nagai, K. (2018). Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis\u2014The ANSWER cohort study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194130"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13075-019-1897-8","article-title":"Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis\u2014The ANSWER cohort study","volume":"21","author":"Ebina","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_10","first-page":"e1","article-title":"Compliance and cost of biologic therapies for rheumatoid arthritis","volume":"9","author":"Bonafede","year":"2017","journal-title":"Am. J. Pharm. Benefits"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/qjmed\/hcm015","article-title":"Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis","volume":"100","author":"Niewold","year":"2007","journal-title":"QJM Int. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/art.40061","article-title":"Editorial: Prevention of rheumatoid arthritis: Now is the time, but how to proceed?","volume":"69","author":"Deane","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-018-0754-0","article-title":"Preclinical rheumatoid arthritis and rheumatoid arthritis prevention","volume":"20","author":"Deane","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.rdc.2010.02.001","article-title":"Preclinical rheumatoid arthritis: Identification, evaluation, and future directions for investigation","volume":"36","author":"Deane","year":"2010","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cen.12294","article-title":"The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment","volume":"80","author":"An","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1745-6215-14-226","article-title":"Effect of berberine on insulin resistance in women with polycystic ovary syndrome: Study protocol for a randomized multicenter controlled trial","volume":"14","author":"Li","year":"2013","journal-title":"Trials"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"Zhang","year":"2010","journal-title":"Metabolism"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ptr.5475","article-title":"A Randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome","volume":"29","author":"Chen","year":"2015","journal-title":"Phyther. Res."},{"key":"ref_20","first-page":"42","article-title":"Review of the efficacy and safety of topical mahonia aquifolium for the treatment of psoriasis and atopic dermatitis","volume":"11","author":"Janeczek","year":"2018","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1475-2891-8-38","article-title":"Phellodendron and citrus extracts benefit joint health in osteoarthritis patients: A pilot, double-blind, placebo-controlled study","volume":"8","author":"Oben","year":"2009","journal-title":"Nutr. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9149(03)00533-2","article-title":"Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"92","author":"Zeng","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yan, H.-M., Xia, M.-F., Wang, Y., Chang, X.-X., Yao, X.-Z., Rao, S.-X., Zeng, M.-S., Tu, Y.-F., Feng, R., and Jia, W.-P. (2015). Efficacy of berberine in patients with non-alcoholic fatty liver disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134172"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/art.30202","article-title":"Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis","volume":"63","author":"Hu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s10753-014-9909-y","article-title":"Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects","volume":"37","author":"Wang","year":"2014","journal-title":"Inflammation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.biopha.2017.02.099","article-title":"Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthritis in rats","volume":"89","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1111\/febs.14147","article-title":"Berberine ameliorates collagen-induced arthritis in rats by suppressing Th17 cell responses via inducing cortistatin in the gut","volume":"284","author":"Yue","year":"2017","journal-title":"FEBS J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"289264","DOI":"10.1155\/2014\/289264","article-title":"Antioxidant and Anti-inflammatory activities of berberine in the treatment of diabetes mellitus","volume":"2014","author":"Li","year":"2014","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_29","first-page":"G504","article-title":"Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice","volume":"302","author":"Yan","year":"2012","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.phrs.2016.02.010","article-title":"Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL\/6 mice by suppressing Th17 responses","volume":"110","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1179\/1743132812Y.0000000156","article-title":"The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis","volume":"35","author":"Jiang","year":"2013","journal-title":"Neurol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wang, H., Tu, S., Yang, S., Shen, P., Huang, Y., Ba, X., Lin, W., Huang, Y., Wang, Y., and Qin, K. (2019). Berberine modulates LPA function to inhibit the proliferation and inflammation of FLS-RA via p38\/ERK MAPK pathway mediated by LPA1. Evid. Based Complement. Altern. Med., 2019.","DOI":"10.1155\/2019\/2580207"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10495-019-01548-6","article-title":"Berberine mitigates IL-21\/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17\/Treg imbalance in rheumatoid arthritis","volume":"24","author":"Dinesh","year":"2019","journal-title":"Apoptosis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"106830","DOI":"10.1016\/j.intimp.2020.106830","article-title":"Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK\/ HIF-1\u03b1 pathway","volume":"87","author":"Yu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1111\/jcmm.15803","article-title":"Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08935-6","article-title":"T cell specific Cxcr5 deficiency prevents rheumatoid arthritis","volume":"7","author":"Moschovakis","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.biopha.2017.10.132","article-title":"Novel function of hydroxychloroquine: Down regulation of T follicular helper cells in collagen-induced arthritis","volume":"97","author":"Han","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/annrheumdis-2016-209830","article-title":"Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: A systematic literature review and meta-analysis","volume":"76","author":"Dekkers","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-065X.2009.00773.x","article-title":"Molecular mechanisms of T-cell receptor and costimulatory molecule ligation\/blockade in autoimmune disease therapy","volume":"229","author":"Podojil","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.11063","article-title":"CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis","volume":"48","author":"Morgan","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/smim.1994.1039","article-title":"CD40 ligation in B cell activation, isotype switching and memory development","volume":"6","author":"Gray","year":"1994","journal-title":"Semin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1359-6101(03)00024-8","article-title":"The CD40\u2013CD154 interaction in B cell\u2013T cell liaisons","volume":"14","author":"Bishop","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0167-5699(94)90269-0","article-title":"The role of CD40 in the regulation of humoral and cell-mediated immunity","volume":"15","author":"Durie","year":"1994","journal-title":"Immunol. Today"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","article-title":"Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40","volume":"261","author":"Durie","year":"1993","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/eji.1830261008","article-title":"Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: Requirement for both B7-1 and B7-2","volume":"26","author":"Webb","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/jaut.2001.0527","article-title":"Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-\u03b3 in Anti-B7-mediated suppression of disease","volume":"17","author":"Tellander","year":"2001","journal-title":"J. Autoimmun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41598-018-20566-z","article-title":"Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12739","article-title":"Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis","volume":"183","author":"Vierboom","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2007.08.001","article-title":"Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis","volume":"7","author":"Cho","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/art.39611","article-title":"C\u03b31 deficiency exacerbates collagen-induced arthritis","volume":"68","author":"Strait","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4049\/jimmunol.169.1.454","article-title":"Complement deficiency ameliorates collagen-induced arthritis in mice","volume":"169","author":"Hietala","year":"2002","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.4049\/jimmunol.164.8.4340","article-title":"A role for complement in antibody-mediated inflammation: C5-Deficient DBA\/1 mice are resistant to collagen-induced arthritis","volume":"164","author":"Wang","year":"2000","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/ar3119","article-title":"A multiparameter approach to monitor disease activity in collagen-induced arthritis","volume":"12","author":"Seeuws","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.4049\/jimmunol.158.11.5514","article-title":"Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice","volume":"158","author":"Mikulowska","year":"1997","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/eji.1830261219","article-title":"Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice","volume":"26","author":"McIntyre","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/bp020068d","article-title":"Improvement of monoclonal antibody production in hybridoma cells by dimethyl sulfoxide","volume":"19","author":"Ling","year":"2003","journal-title":"Biotechnol. Prog."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"key":"ref_62","unstructured":"Hooke Laboratories (2019, May 20). CIA Induction in DBA\/1 Mice. Available online: https:\/\/hookelabs.com\/protocols\/ciaInduction_DBA1.html."},{"key":"ref_63","unstructured":"Chondrex Inc. (2011). Mouse Anti-Type I and Type II Collagen IgG Assay Kit with TMB Standard ELISA Kit, Chondrex Inc."},{"key":"ref_64","unstructured":"Chondrex Inc. (2019, November 01). Mouse Anti-Type II Collagen IgG Subtype Antibody Assay Kit with TMB. Available online: https:\/\/www.chondrex.com\/documents\/Mouse ELISA Subtype TMB.pdf."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3522\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:25:33Z","timestamp":1760361933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["ijms22073522"],"URL":"https:\/\/doi.org\/10.3390\/ijms22073522","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/736264","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}